3-126488206-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_144639.3(UROC1):c.1782C>T(p.Gly594Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00268 in 1,614,064 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0028 ( 9 hom. )
Consequence
UROC1
NM_144639.3 synonymous
NM_144639.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.847
Genes affected
UROC1 (HGNC:26444): (urocanate hydratase 1) This gene encodes an enzyme involved in the second step of histidine catabolism, metabolizing urocanic acid to formiminoglutamic acid. Deficiency of this enzyme results in urocanic aciduria, and is an apparent cause of mental retardation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 3-126488206-G-A is Benign according to our data. Variant chr3-126488206-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 726175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UROC1 | NM_144639.3 | c.1782C>T | p.Gly594Gly | synonymous_variant | 18/20 | ENST00000290868.7 | NP_653240.1 | |
UROC1 | NM_001165974.2 | c.1962C>T | p.Gly654Gly | synonymous_variant | 19/21 | NP_001159446.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UROC1 | ENST00000290868.7 | c.1782C>T | p.Gly594Gly | synonymous_variant | 18/20 | 1 | NM_144639.3 | ENSP00000290868.2 | ||
UROC1 | ENST00000383579.3 | c.1962C>T | p.Gly654Gly | synonymous_variant | 19/21 | 1 | ENSP00000373073.3 |
Frequencies
GnomAD3 genomes AF: 0.00190 AC: 289AN: 152090Hom.: 1 Cov.: 34
GnomAD3 genomes
AF:
AC:
289
AN:
152090
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00196 AC: 493AN: 251472Hom.: 3 AF XY: 0.00213 AC XY: 289AN XY: 135908
GnomAD3 exomes
AF:
AC:
493
AN:
251472
Hom.:
AF XY:
AC XY:
289
AN XY:
135908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00276 AC: 4031AN: 1461856Hom.: 9 Cov.: 32 AF XY: 0.00274 AC XY: 1990AN XY: 727226
GnomAD4 exome
AF:
AC:
4031
AN:
1461856
Hom.:
Cov.:
32
AF XY:
AC XY:
1990
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00190 AC: 289AN: 152208Hom.: 1 Cov.: 34 AF XY: 0.00179 AC XY: 133AN XY: 74428
GnomAD4 genome
AF:
AC:
289
AN:
152208
Hom.:
Cov.:
34
AF XY:
AC XY:
133
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | UROC1: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -8
Find out detailed SpliceAI scores and Pangolin per-transcript scores at